Foundation Fighting Blindness Retinal Degeneration Fund
Director at IRD
- Sold, on record
- $18.8M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Sep 30, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- IRDOpus Genetics, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
1
No plan
2
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 4 sale IRDUnusualDec 9, 2025 2025
Sold 4M shares at $2.15 ($8.6M)
Foundation Fighting Blindness Retinal Degeneration Fund, Director
No 10b5-1 planSold 42.1% of holdings ($20.4M position)5.5M shares leftFirst sale on recordFiling
- 2 Form 4 sale IRDUnusualMay 18, 2026 +160 days
Sold 1.7M shares at $4.35 ($7.4M)
Foundation Fighting Blindness Retinal Degeneration Fund, Director
No 10b5-1 planSold 31% of holdings ($23.9M position)3.8M shares leftFiling
- 3 Form 4 sale IRDNo planSep 30, 2026 +135 days
Sold 556,000 shares at $4.96 ($2.8M)
Foundation Fighting Blindness Retinal Degeneration Fund, Director
No 10b5-1 planSold 14.7% of holdings ($18.8M position)3.2M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 2, 2026 | IRD | Director | Form 4 sale | 556,000 | $2.8M | 14.7% | No plan | SEC |
| May 18, 2026 | May 20, 2026 | IRD | Director | Form 4 sale | 1.7M | $7.4M | 31.0% | Unusual | SEC |
| Dec 9, 2025 | Dec 11, 2025 | IRD | Director | Form 4 sale | 4M | $8.6M | 42.1% | Unusual | SEC |